Pneumocystosis

Catherine F. Decker; Henry Masur

doi:10.1007/978-1-4419-6640-7_26

Pneumocystosis

Catherine F. Decker, Henry Masur^*

^*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

2 Scopus citations

Abstract

Although considered an organism of low virulence, Pneumocystis jiroveci is an important cause of pneumonia in immunocompromised hosts, especially those with hematologic malignancies, organ transplants, HIV infection, certain congenital immunodeficiencies, and those receiving potent immunosuppressive drugs [1-8]. As the population of immunosuppressed patients has grown, and as our ability to detect organisms in respiratory specimens has improved, more and more cases have been recognized in the period 1970-2000 [1-3]. Pneumocystis infections continue to cause morbidity and mortality among susceptible patients who do not receive chemoprophylaxis.

Original language	English
Title of host publication	Essentials of Clinical Mycology
Subtitle of host publication	Second Edition
Publisher	Springer New York
Pages	437-453
Number of pages	17
ISBN (Electronic)	9781441966407
ISBN (Print)	9781441966391
DOIs	https://doi.org/10.1007/978-1-4419-6640-7_26
State	Published - 2011
Externally published	Yes

Access to Document

10.1007/978-1-4419-6640-7_26

Cite this

@inbook{3d5a2211233942e6b083e098636ba02f,

title = "Pneumocystosis",

abstract = "Although considered an organism of low virulence, Pneumocystis jiroveci is an important cause of pneumonia in immunocompromised hosts, especially those with hematologic malignancies, organ transplants, HIV infection, certain congenital immunodeficiencies, and those receiving potent immunosuppressive drugs [1-8]. As the population of immunosuppressed patients has grown, and as our ability to detect organisms in respiratory specimens has improved, more and more cases have been recognized in the period 1970-2000 [1-3]. Pneumocystis infections continue to cause morbidity and mortality among susceptible patients who do not receive chemoprophylaxis.",

author = "Decker, {Catherine F.} and Henry Masur",

year = "2011",

doi = "10.1007/978-1-4419-6640-7_26",

language = "English",

isbn = "9781441966391",

pages = "437--453",

booktitle = "Essentials of Clinical Mycology",

publisher = "Springer New York",

}

TY - CHAP

T1 - Pneumocystosis

AU - Decker, Catherine F.

AU - Masur, Henry

PY - 2011

Y1 - 2011

N2 - Although considered an organism of low virulence, Pneumocystis jiroveci is an important cause of pneumonia in immunocompromised hosts, especially those with hematologic malignancies, organ transplants, HIV infection, certain congenital immunodeficiencies, and those receiving potent immunosuppressive drugs [1-8]. As the population of immunosuppressed patients has grown, and as our ability to detect organisms in respiratory specimens has improved, more and more cases have been recognized in the period 1970-2000 [1-3]. Pneumocystis infections continue to cause morbidity and mortality among susceptible patients who do not receive chemoprophylaxis.

AB - Although considered an organism of low virulence, Pneumocystis jiroveci is an important cause of pneumonia in immunocompromised hosts, especially those with hematologic malignancies, organ transplants, HIV infection, certain congenital immunodeficiencies, and those receiving potent immunosuppressive drugs [1-8]. As the population of immunosuppressed patients has grown, and as our ability to detect organisms in respiratory specimens has improved, more and more cases have been recognized in the period 1970-2000 [1-3]. Pneumocystis infections continue to cause morbidity and mortality among susceptible patients who do not receive chemoprophylaxis.

UR - http://www.scopus.com/inward/record.url?scp=84920365125&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-6640-7_26

DO - 10.1007/978-1-4419-6640-7_26

M3 - Chapter

AN - SCOPUS:84920365125

SN - 9781441966391

SP - 437

EP - 453

BT - Essentials of Clinical Mycology

PB - Springer New York

ER -

Pneumocystosis

Abstract

Access to Document

Fingerprint

Cite this